[HTML][HTML] Venous thromboembolism in patients discharged after COVID-19 hospitalization
MM Engelen, C Vandenbriele… - … in thrombosis and …, 2021 - thieme-connect.com
Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …
[HTML][HTML] Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis
We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
Anticoagulation before hospitalization is a potential protective factor for COVID‐19: insight from a French multicenter cohort study
Background Coronavirus disease 2019 (COVID‐19) is a respiratory disease associated with
thrombotic outcomes with coagulation and endothelial disorders. Based on that, several …
thrombotic outcomes with coagulation and endothelial disorders. Based on that, several …
[HTML][HTML] Clinical management of adult patients with COVID-19 outside intensive care units: guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the …
M Bassetti, DR Giacobbe, P Bruzzi, E Barisione… - Infectious Diseases and …, 2021 - Springer
Abstract Introduction The Italian Society of Anti-Infective Therapy (SITA) and the Italian
Society of Pulmonology (SIP) constituted an expert panel for developing evidence-based …
Society of Pulmonology (SIP) constituted an expert panel for developing evidence-based …
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
AK Pasha, RD McBane, R Chaudhary, LJ Padrnos… - Thrombosis research, 2021 - Elsevier
Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …
patients varies widely depending on patient populations sampled and has been …
Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID‐19
JP Quintal Martínez… - Phytotherapy …, 2023 - Wiley Online Library
The SARS‐CoV‐2 outbreak has been one of the largest public health crises globally, while
thrombotic complications have emerged as an important factor contributing to mortality …
thrombotic complications have emerged as an important factor contributing to mortality …
[HTML][HTML] Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
S Zhang, Y Li, G Liu, B Su - Thrombosis Journal, 2021 - Springer
Background Anticoagulation in hospitalized COVID-19 patients has been associated with
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …
[HTML][HTML] High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
Thromboprophylaxis in hospitalized patients with COVID-19 has been associated with a
survival benefit and is strongly recommended. However, the optimal dose of …
survival benefit and is strongly recommended. However, the optimal dose of …
[HTML][HTML] Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
WS Hoogenboom, JQ Lu, B Musheyev, L Borg… - PLoS …, 2022 - journals.plos.org
Introduction Although patients with severe COVID-19 are known to be at high risk of
developing thrombotic events, the effects of anticoagulation (AC) dose and duration on in …
developing thrombotic events, the effects of anticoagulation (AC) dose and duration on in …
[HTML][HTML] Neurologic and neuroscientific evidence in aged COVID-19 patients
The COVID-19 pandemic continues to prevail as a catastrophic wave infecting over 111
million people globally, claiming 2. 4 million lives to date. Aged individuals are particularly …
million people globally, claiming 2. 4 million lives to date. Aged individuals are particularly …